Background: In India, presently 72.9 million people are living with diabetes, which is expected to reach 134.3 million by the year 2045. The glycosylated haemoglobin (HbA1c) test is the most widely accepted laboratory test for evaluating long term glycemic control. Patient’s understanding of HbA1c can lead to better glycemic control. Aims and Objectives: (1) To determine the awareness and level of understanding of HbA1c among type 2 DM patients. Material and methods: A cross-sectional study was conducted among Type 2 DM patients undergoing routine follow up in a private clinic. A predesigned questionnaire was administered to the patients, which assessed their awareness and understanding of HbA1c. Result: A total of 128 participants were recruited. 68% of the participants were male and 32% were females. 93 participants had attained primary education, remaining 35 participants had attained education above primary level. Thirty five (27.3%) were aware of the term HbA1c.Conclusion: The current study indicates inadequate knowledge of HbA1C among diabetic patients. This lack of knowledge and awareness may lead to increased susceptibility to the development of diabetic complications, and potentially higher healthcare costs among these patients. It is our recommendation that policy makers focus on strategies that address HbA1C test accessibility to everyone and everywhere, so as to effectively monitor and combat DM. Key words: Awareness, HbA1c